Search results
Should breast cancer screening age be lowered in Canada? Task force says no — but advocates are...
Yahoo Canada Style· 21 hours agoThe guidelines state that women aged 40-49 who have been informed of the "benefits and harms" of...
FDA’s review of MDMA for PTSD highlights study bias and safety concerns
Ars Technica· 12 hours agoFurther ReadingMDMA—aka ecstasy—submitted to FDA as part of PTSD therapyOn Tuesday, June 4, the FDA...
When Companies Ask for Your Social Security Number, Try Saying No
The Wall Street Journal· 22 hours agoOf course, in some cases, a company won’t back down—and you have to decide if your concerns about...
A Promising New Blood Test for Colorectal Cancer Is in the Works—Here’s What You Should Know
Self via Yahoo News· 22 hours agoThe FDA—which usually listens to such panels, but not always—still has...
How to Choose an LED Therapy Mask, According to Dermatologists
The Wall Street Journal· 41 minutes agoLED, or light-emitting diode, therapy devices are the latest trend to hit this beauty space. Unlike...
Solar project to destroy thousands of Joshua trees in the Mojave Desert
LA Times via Yahoo News· 1 day agoBoron residents worry the construction work will increase the risk of contracting valley fever....
Residents speak out against local officials for spraying hazardous herbicides making them ill: 'We...
The Cool Down via Yahoo News· 4 days agoHowever, that doesn't mean that residents aren't feeling the effects. What could the AVCA do...
A day in the sun for a new sunscreen?
Politico· 20 hours agoThey’re using different types of “guardrails” to try to offer the drugs under their insurance plans to patients with the best chances for success, but some pharmacy benefit
Italy’s Po Delta is a nature-rich UNESCO reserve. Now it is at risk from offshore drilling
Euronews via Yahoo News· 3 days ago“We are already overwhelmed by the blue crab, now the drills: werisk definitive collapse,” said...
FDA Approves First Interchangeable Biosimilar for Two Rare Diseases
Clearfield Progress· 4 days agoToday, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. "Many rare conditions ...
